SQZ Biotech

134 Coolidge Ave
Second Floor
United States

Tel: (603) 490-9117

Show jobs for this employer

84 articles about SQZ Biotech

  • Although the clinical trial news last week was dominated by the stunning reversal of Biogen and Eisai’s clinical trials of aducanumab for Alzheimer’s disease, there was plenty of other trial news. Here’s a look.
  • Biopharma companies strengthen their senior leadership teams and boards of directors.
  • In the first quarter of 2019, more than 30 life science companies* announced  expansions, new locations, increased funding, new trial and product launches and various other news pointing to a growing industry.
  • SQZ Biotech is on a roll. Months after securing $72 million in a Series C financing round and expanding a developmental agreement with pharma giant Roche worth up to $1 billion, the company is now expanding its footprint in Watertown, Mass.